Literature DB >> 13216834

Further observation on the uricosuric effects of probenecid (benemid) in tophaceous gout.

A B GUTMAN, T F YU, V RANDOLPH.   

Abstract

Entities:  

Keywords:  GOUT; PROBENECID/therapeutic use; URIC ACID/in urine; URINE

Mesh：

Substances：

Year:  1954        PMID： 13216834

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  5 in total

1.  Evaluation of uricosuric agents in chronic gout.

Authors:  M A OGRYZLO; J HARRISON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.

Authors:  T F YU; B C PATON; T CHENKIN; J J BURNS; B B BRODIE; A B GUTMAN
Journal:  J Clin Invest       Date:  1956-04       Impact factor: 14.808

3.  Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.

Authors:  Sophie L Stocker; Kenneth M Williams; Andrew J McLachlan; Garry G Graham; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations.

Authors:  Hiroshi Miyata; Tappei Takada; Yu Toyoda; Hirotaka Matsuo; Kimiyoshi Ichida; Hiroshi Suzuki
Journal:  Front Pharmacol       Date:  2016-12-27       Impact factor: 5.810

5.  OAT10/SLC22A13 Acts as a Renal Urate Re-Absorber: Clinico-Genetic and Functional Analyses With Pharmacological Impacts.

Authors:  Yu Toyoda; Yusuke Kawamura; Akiyoshi Nakayama; Keito Morimoto; Seiko Shimizu; Yuki Tanahashi; Takashi Tamura; Takaaki Kondo; Yasufumi Kato; Kimiyoshi Ichida; Hiroshi Suzuki; Nariyoshi Shinomiya; Yasushi Kobayashi; Tappei Takada; Hirotaka Matsuo
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.